Eli Lilly's Mounjaro receives FDA approval to reduce heart disease risks
Eli Lilly's Mounjaro receives FDA approval to reduce heart disease risks. 58 clean stories shaped this window, with sentiment leaning bearish at 43/100. Also in focus: Nvidia pauses financing program that gave AI cloud providers credit support for revenue share, WSJ reports.
Sentiment43/100 · Leaning Bearish
Market readLeaning Bearishat publication
Stories58clean stories in the window
Published9:35 AMFri, Aug 28 · ET